Covaxin

Vaccine approval hailed as decisive turning point in India’s fight against pandemic; Leaders laud scientists, corona warriors

10:46 pm January 3, 2021

New Delhi : The approval given to two COVID-19 vaccines is a ”decisive turning point” in the spirited fight against the pandemic, Prime Minister Narendra Modi said on Sunday as the development was greeted with a sense of relief and hope in the country that has been reeling from the impact of the virus for […]

India approves Oxford’s, Bharat Biotech’s COVID-19 vaccines for restricted emergency use

4:50 pm January 3, 2021

New Delhi: India’s drugs regulator on Sunday approved Oxford COVID-19 vaccine Covishield, manufactured by the Serum Institute, and indigenously developed Covaxin of Bharat Biotech for restricted emergency use in the country, paving the way for a massive inoculation drive. The Drugs Controller General of India (DCGI) granted the approval on the basis of recommendations by a COVID-19 Subject Expert Committee (SEC) […]

Around 400 new COVID-19 cases in Delhi: Kejriwal

Kejriwal lauds scientists and doctors after approval to two COVID vaccines

4:45 pm January 3, 2021

New Delhi: Delhi Chief Minister Arvind Kejriwal on Sunday said that approval for the emergency use of two ”made in India” vaccines will give a positive direction to the country’s fight against coronavirus. Congratulating the countrymen, Kejriwal saluted the scientists and doctors for the achievement. The Drugs Controller General of India (DCGI) on Sunday approved Oxford COVID-19 […]

WHO welcomes India’s COVID-19 vaccine approval

3:56 pm January 3, 2021

New Delhi : The World Health Organisation on Sunday welcomed India’s decision giving emergency use authorisation to COVID-19 vaccines, saying it will help ”intensify” and ”strengthen” its fight against the ongoing pandemic. India’s drugs regulator has approved Oxford COVID-19 vaccine Covishield, manufactured by the Serum Institute, and indigenously developed Covaxin of Bharat Biotech for restricted emergency use in the […]

Delhi has less than a day’s stock of Covaxin for 45-plus age group: Atishi

Bharat Biotech on course to have 26,000 volunteers for Phase-3 clinical trials of Covaxin

11:28 pm January 2, 2021

New Delhi: Bharat Biotech on Saturday said it is moving towards achieving the target of having 26,000 volunteers across the country for Phase-3 trials of its Covid-19 vaccine ‘Covaxin’. The company has already roped in 23,000 volunteers for the trials, it said. The company statement has come after an expert panel of India’s central drug […]